Stay updated on REGONIVO in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the REGONIVO in Colorectal Cancer Clinical Trial page.

Latest updates to the REGONIVO in Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check40 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check47 days agoChange DetectedThe latest updates include the posting of results on January 24, 2025, and detailed definitions and evaluations of Dose Limiting Toxicities (DLTs) related to the administration of Regorafenib and Nivolumab, while several previous entries regarding earlier results and definitions have been removed.SummaryDifference78%
- Check54 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check61 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.3%
Stay in the know with updates to REGONIVO in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGONIVO in Colorectal Cancer Clinical Trial page.